Increased Concordance Rates Between Embryo Cell-Free Dna and Trophectoderm Biopsies Are Related to Female Age Independently of Culture Conditions

Rubio, Carmen; Navarro-Sánchez, Luis; García-Pascual, Carmen M.; Ocali, Olcay; Cimadomo, Danilo; Venier, William; Barroso, Gerardo; Kopcow, L.; Bahçeci, Mustafa; López-Yañez, Lourdes; Kulmann, Marcos Iuri Roos; Fuente, Emilio de la; Navarro, Roser; Valbuena, Diana; Sakkas, Denny; Rienzi, Laura; Simón, Carlos

doi:10.1016/j.fertnstert.2020.08.1069

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The origin of the embryonic cfDNA is uncertain, a recent study (Rubio et al 2020) has found similar concordance rates of the cfDNA with TE biopsy and with the inner cell mass biopsy (87.5 and 84.5%, respectively). In another publication, it was suggested that the cfDNA could be more representative of the chromosome content of the full blastocyst than the TE biopsy, due to the high concordance rates observed with the whole blastocyst (Huang et al 2019).…”

Section: Non-invasive Pgt-a (Nipgt-a)mentioning

confidence: 83%

PREIMPLANTATION GENETIC TESTING: Chromosome abnormalities in human embryos

Rubio

Rodrigo²,

Simón

2020

Reproduction

Self Cite

View full text Add to dashboard Cite

Aneuploidy is a frequent event in human embryos, and its incidence is higher in oocytes and embryos from women of advanced maternal age. Aneuploidy may also be a contributing factor in infertile populations, such as couples with recurrent miscarriages, repetitive implantation failure, or male infertility. For these reasons, preimplantation genetic testing for aneuploidy (PGT-A) has been proposed to prevent miscarriages and increase live birth rates in infertile couples undergoing in vitro fertilization. Next generation sequencing is currently being applied for the detection of aneuploidies in human embryos, including whole chromosome aneuploidies, segmental aneuploidies, uniform, and mosaic aneuploidies. More recently, this technology has been incorporated for the analysis of the cell-free DNA secreted by the embryo to the culture media. Chromosome abnormalities mostly originate in female meiosis. Recombination between homologous chromosomes is a critical event that occurs in the foetal ovary. The importance of altered recombination pertains to paternally as well as maternally derived trisomies, but as most aneuploidy arises during oogenesis, the female is at greater risk. For males, sperm concentration is associated with higher risk of aneuploid sperm and thus aneuploid embryos. Mitosis errors can occur at all stages of early embryo development that result in chromosomally distinct cell populations. The clinical impact of mosaicism depends on the mosaicism type, location, and number of aneuploid cells. Transfer of mosaic embryos has been proposed when no euploid embryos are available in the PGT-A cycle.

show abstract

Section: Non-invasive Pgt-a (Nipgt-a)mentioning

confidence: 83%